Liberum IME are delighted to announce the appointment of Mamuda Aminu (MD, MSc, PhD) to the role of Medical Director, responsible for the content development of its independent and accredited medical education programmes. He will be working closely with the Liberum team to develop new programmes and grant requests, and will offer strategic insight to help grow the business across 2021.
Formally Senior Clinical Research Associate at the Liverpool School of Tropical Medicine and a freelance consultant, Mamuda brings over ten years of experience in clinical research, medical education and medical writing in multiple therapeutic areas, such as anti-infectives, oncology, medical devices, cardiovascular diseases, diabetes and rare diseases.
Mamuda is also a qualified physician and spent several years working in HIV, child nutrition, and maternal, newborn and child health. He was appointed Medical Director by the Katsina State Health Services Management Board in Nigeria; this was followed by a role as the State Programme Officer for the PRRINN-MNCH (Maternal, Newborn and Child Health) programme in the UK Department for International Development (DFID).
Additionally, Mamuda holds an MSc in International Public Health from the Liverpool School of Tropical Medicine, and a PhD in Tropical Medicine & International Public Health from the University of Liverpool.
Mamuda will be working with the IME team across multiple therapy areas to create independent, grant-funded education for healthcare professionals based on identified educational needs, in adherence with the good Continuing Medical Education practice (gCMEp) guidelines.
Mamuda will be reporting to the Managing Director of Liberum IME, Celeste Kolanko, who said:
“Mamuda’s impressive wealth of scientific knowledge, his clinical experience and his insight into the educational needs of the healthcare community will enhance the strong Liberum team and help us to continue to grow. We look forward to taking the next steps in creating education that will improve clinical practice and, in turn, create better outcomes for patients.”